HLA-DRB1*15:01与HLA-DRB3*02:02在PLA2R相关膜性肾病中的作用
研究对中国人群99例PLA2R相关膜性肾病、50例PLA2R无关膜性肾病及100名健康对照进行MHC区域测序,发现HLA-DRB1*15:01和HLA-DRB3*02:02独立且强关联PLA2R相关膜性肾病,并在独立队列293例患者和285名健康对照中验证;联合分析显示两等位基因携带者患病风险显著升高。
要点
- HLA-DRB1*15:01和HLA-DRB3*02:02独立且强关联中国人群PLA2R相关膜性肾病
- 98.7%的PLA2R相关膜性肾病患者携带至少一个HLA风险等位基因,而对照组为43.9%
- 携带任一风险等位基因者患PLA2R相关膜性肾病的比值比为98.9
核心结论
- HLA-DRB1*15:01和HLA-DRB3*02:02等位基因在中国人群中独立且强关联PLA2R相关膜性肾病。
研究设计与样本
- 对99例PLA2R相关膜性肾病患者、50例PLA2R无关膜性肾病患者和100名健康对照的DNA样本进行整个MHC区域测序。
- 在独立队列293例PLA2R相关膜性肾病患者和285名健康对照中进行验证。
主要发现
- 联合分析中,多因素logistic回归模型证实HLA-DRB1*15:01与PLA2R相关膜性肾病关联(OR 24.9,95%CI 15.3至42.6,P=2.3×10-35)。
- HLA-DRB3*02:02与PLA2R相关膜性肾病独立且强关联(OR 17.7,95%CI 11.0至30.3,P=8.0×10-29)。
- 98.7%的PLA2R相关膜性肾病患者携带至少一个HLA风险等位基因,而对照组为43.9%。
- 携带任一风险等位基因者患PLA2R相关膜性肾病的比值比为98.9(95%CI 44.4至281.7,P=2.5×10-23)。
- HLA风险等位基因还与PLA2R相关膜性肾病患者的发病年龄相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Idiopathic membranous nephropathy (MN) is associated with HLA; however, the HLA allele involved remains unknown. To identify the HLA risk alleles associated with phospholipase A2 receptor (PLA2R)-related MN in the Chinese population, we sequenced the entire MHC region in DNA samples from 99 patients with PLA2R-related MN, 50 patients with PLA2R-unrelated MN, and 100 healthy subjects. Two HLA risk alleles, HLA-DRB1*15:01 and HLA-DRB3*02:02, independently and strongly associated with an increased risk of PLA2R-related MN. After adjusting for HLA-DRB1*15:01 and HLA-DRB3*02:02, no other alleles showed significant association with PLA2R-related MN. A replication study in an independent cohort of 293 participants with PLA2R-related MN and 285 healthy controls validated these findings. In a joint analysis, a multivariate logistic regression model confirmed that HLA-DRB1*15:01 (odds ratio [OR], 24.9; 95% confidence interval [95% CI], 15.3 to 42.6; P=2.3×10-35) and HLA-DRB3*02:02 (OR, 17.7; 95% CI, 11.0 to 30.3; P=8.0×10-29) independently and strongly associated with PLA2R-related MN. As many as 98.7% of patients with PLA2R-related MN, compared with 43.9% of control subjects, carried at least one HLA risk allele. Subjects with either risk allele had higher odds of developing PLA2R-related MN than those without a risk allele (OR, 98.9; 95% CI, 44.4 to 281.7; P=2.5×10-23). These HLA risk alleles also associated with the age at disease onset in patients with PLA2R-related MN. In conclusion, our findings provide clear evidence that the HLA-DRB1*15:01 and HLA-DRB3*02:02 alleles independently and strongly associate with PLA2R-related MN in the Chinese population.
引用
- Le WB, Shi JS, Zhang T, et al. HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy. J Am Soc Nephrol. 2016. PMID: 28028136. doi:10.1681/ASN.2016060644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。